News
AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025: Cambridge, UK Wednesday, May 14, 2025, 13:0 ...
In the domestic brewery segment, increased sales contribution from the beer category should help drive margin improvement. Kirin has increased its marketing investments for Harekaze and Hyoketsu, ...
The chronic pruritus market is expected to grow across the 7MM, driven by the introduction of innovative therapies like ...
Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...
North Carolina officials are expected to announce another major corporate deal as early as Monday — one that could bring an ...
Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results